EASD 2020: Results from the TIMES 3 trial – efficacy and safety of imeglimin in combination with insulin in Japanese patients with type 2 diabetes

The study demonstrates that imeglimin, in combination with insulin, produces clinically significant glycemic control without increasing the risk of hypoglycemia. Credit: Shutterstock + goffkein.pro.



  • Imeglimin